Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Arkema    AKE   FR0010313833

ARKEMA (AKE)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

ARKEMA : Successful Third Share Capital Increase Operation Reserved for Arkema Employees

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/20/2012 | 11:45am CET

Regulatory News:

With 6,150 employees and former employees subscribing for 535,013 shares totalling 29.2 million euros, the third capital increase operation reserved for Arkema (Paris:AKE) employees has set a record in terms of amount invested and number of participants. This operation is a reflection of the employees' confidence in the development of their Group. The share of Arkema's capital held by its employees now stands at 5.5%.

Four years after the initial operation, and with a desire to keep on involving its employees and former employees closely in the growth of the Group, Arkema successfully conducted a third capital increase on April 18th 2012. This involved 6,150 subscribers from 21 countries, i.e. a 50% increase compared to the 2010 operation, and a total investment of 29.2 million euros, 80% up. Almost 20% of these subscriptions came from employees outside France.

The subscription period spanned March 12th to 25th 2012. The subscription price was set at ?54.51 per share by the Board of Directors meeting on March 7th 2012; this corresponds to the average opening price of the Arkema share quoted on the Paris stock exchange in the last 20 trading days prior to the date of this Board of Directors meeting minus a 20% discount.

Arkema's share capital has increased to 623,995,900 euros, divided into 62,399,590 shares, with employee share ownership rising from 4.7% to almost 5.5%.

A global chemical company and France's leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 13,200 employees and 9 research centers, Arkema generates annual revenue of ?5.9 billion*, and holds leadership positions in all its markets with a portfolio of internationally recognized brands. The world is our inspiration.
*Sales and headcount for continuing activities at end 2011, excluding vinyl products activities, which are part of a divestment plan.

ARKEMA www.arkema.com

420, rue d'Etienne d'Orves -

F-92705 COLOMBES Cedex

Standard : +33 (0)1 49 00 80 80 - Fax : +33 (0)1 49 00 83 96

Société anonyme au capital de 623 995 900 euros
445 074 685 RCS Nanterre

Investor Relations:
Sophie Fouillat
Tel. : +33 1 49 00 86 37
E-mail : [email protected]
Jérôme Raphanaud
Tel. : +33 1 49 00 72 07
E-mail : [email protected]
or
Press Relations:
Sybille Chaix
Tel. : +33 1 49 00 70 30
E-mail : [email protected]


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ARKEMA
12/14 ARKEMA : Patent Issued for E-1-Chloro-3,3,3-Trifluoropropene Production Process ..
12/07 ARKEMA : Patent Issued for Hydrochloric Acid Purification Process (USPTO 9828314..
12/07 ARKEMA : Patent Application Titled "Thermoplastic Composite Material Made of a S..
12/07 ARKEMA : Patent Issued for Process for the Manufacture of 2,3,3,3-Tetrafluoropro..
11/21 ARKEMA : Patent Issued for Tetrafluoropropene Based Blowing Agent Compositions (..
11/21 ARKEMA : Mini Transat La Boulangere Quentin Vlamynck completes the second leg - ..
11/20 ARKEMA : - Lalou Roucayrol and Alex Pella, winners of the Transat Jacques Vabre ..
11/17 MINI TRANSAT LA BOULANGÈRE : Quentin Vlamynck completes the second leg – i..
11/17 ARKEMA : Harris County Attorney Vince Ryan Sues Arkema
11/16 ARKEMA : Lalou Roucayrol and Alex Pella, winners of the Transat Jacques Vabre in..
More news
News from SeekingAlpha
11/11 Arkema's (ARKAF) Q3 2016 Results - Earnings Call Transcript
11/09 Arkema reports Q3 results
09/08 WALL STREET BREAKFAST : Dollar In The Doldrums
09/08 First responders sue Arkema
09/05 Evacuation order lifted near Arkema's Texas chemical plant
Financials (€)
Sales 2017 8 357 M
EBIT 2017 902 M
Net income 2017 513 M
Debt 2017 1 487 M
Yield 2017 2,26%
P/E ratio 2017 15,12
P/E ratio 2018 13,92
EV / Sales 2017 1,11x
EV / Sales 2018 1,05x
Capitalization 7 784 M
Chart ARKEMA
Duration : Period :
Arkema Technical Analysis Chart | AKE | FR0010313833 | 4-Traders
Technical analysis trends ARKEMA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 114 €
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Thierry le Hénaff Chairman & Chief Executive Officer
Thierry Lemonnier Chief Financial Officer
Bernard L. M. Kasriel Independent Non-Executive Director
Patrice Bréant Director
François Énaud Senior Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ARKEMA9.16%9 203
AIR LIQUIDE12.55%54 629
SHIN-ETSU CHEMICAL CO LTD26.78%44 083
PRAXAIR, INC.28.82%43 309
LYONDELLBASELL INDUSTRIES NV24.90%42 404
GIVAUDAN20.42%21 241